Health
Biocompatible photooxygenation catalyst could be potentially used to treat amyloid diseases – News-Medical.Net
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer’s disease (AD)-related amyloid-β…
Reviewed by Emily Henderson, B.Sc.Nov 25 2020
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer’s disease (AD)-related amyloid-β peptide (Aβ) under near-infrared (NIR) light irradiation is developed.
The catalyst was able to oxygenate Aβ embedded under the skin of a living mouse, and diminished intact Aβ level in AD-model mouse brain. The new catalyst is potentially applicable for the treatment of peripheral amyloid…
-
General13 hours agoGroup armed with machetes attack two teenagers outside Luna Park in St Kilda
-
General23 hours agoFormer March for Australia organiser shut down at latest anti-racism rally
-
Business10 hours agoZip Co posts record Q1 profit growth, lifts outlook
-
General22 hours agoCraig Kelly to Andrew Hastie, ‘Don’t become Leader of the Liberal Party!’